LL
Eli Lilly
LLY · NYSE
$1,123.59 -2.24% (-$25.77)
1M -6.77%
Market Cap $1.09T
P/E Ratio 40.88x
Div. Yield 0.56%
ROE 92.58%
Bulios Fair Price
$747.49
33.5% downside
Trenutna cena
$1,124
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica LLY trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
8/9Valuation
11 /100
Expensive P/B 32.23x
P/S 13.71x
P/E 40.88x
Growth
100 /100
Growing Book val. growth 35.57%
FCF growth 24.94%
EPS growth 51.73%
Profitability
100 /100
Strong FCF margin 25.17%
Op. margin 43.92%
Gross margin 84.01%
Quality
92 /100
Excellent Asset turnover 0.56x
ROA 18.77%
ROIC 27.38%
Debt
67 /100
Low Net debt/EBITDA 1.31x
Int. coverage 34.79x
Debt/Equity 1.62x
Stability
64 /100
Moderate Profitable years 6
EPS volatility 63.96%
Beta 0.50x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o LLY
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
David A. Ricks
Employees
50,000
Headquarters
Indianapolis
Prihajajoči dogodki
29 OKT.
Earnings
Upcoming earnings report